GH Research PLC (GHRS)
NASDAQ·Healthcare·Biotechnology
$29.04
+3.00%
Mkt Cap $1.92B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (13 analysts)
$41.50
Range $32.00 – $65.00
Implied Upside
+42.9%
Consensus $41.50 vs current $29.04
NASDAQ·Healthcare·Biotechnology
$29.04
+3.00%
Mkt Cap $1.92B
Buy
4
Hold
0
Sell
0
Price Target (13 analysts)
$41.50
Range $32.00 – $65.00
+42.9%
Consensus $41.50 vs current $29.04